NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eunkyung Cho, MD, Ph.D
Gachon University Gil Medical Center, Incheon, Republic of Korea
Principal Investigator - Ji-Youn Han, MD. Ph.D
National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea,Asan Medical Center, Songpa-gu, Seoul, Republic of Korea,
Study Chair - Ki Hyeong Lee, MD, Ph.D
Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Republic of Korea
Principal Investigator - Sang-We Kim, MD, Ph.D
Asan Medical Center, Songpa-gu, Seoul, Republic of Korea
Principal Investigator - Young Joo Min, MD, Ph.D
Ulsan University Hospital, Dong-gu, Ulsan, Republic of Korea
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- National Cancer Center
Goyang-si, Gyeonggi-do, South Korea
- Chungbuk National University Hospital
Cheongju-si, North Chungcheong, South Korea
- Asan Medical Center
Songpa-gu, Seoul, South Korea
- Ulsan University Hospital
Dong-gu, Ulsan, South Korea
- Gachon University Gil Medical Center
Incheon, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2013
- Primary completion
- 30 Sept 2014
- Completion
- 30 Sept 2014
- Last update posted
- 14 Aug 2015
- Registered enrollment
- 40
- Registry id
- NCT01718847
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.